INDIANAPOLIS, April 3, 2024 /PRNewswire/ — Neurava announced that it has completed and oversubscribed its Series Seed round, raising $2.26 million. Neurava is developing novel and innovative wearable devices for the estimated 3.5 million Americans and 65 million people worldwide with epilepsy to mitigate the risk of SUDEP, or Sudden Unexpected Death in Epilepsy.
Neurava raises over $2M to advance life-saving epilepsy monitoring device
